Pura Vida Investments’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Hold
450,517
0.85% 15
2026
Q1
$734K Hold
450,517
4.94% 5
2025
Q4
$802K Hold
450,517
3% 5
2025
Q3
$1.09M Hold
450,517
6.62% 5
2025
Q2
$1.02M Hold
450,517
6.15% 6
2025
Q1
$1.21M Hold
450,517
8.85% 4
2024
Q4
$1.18M Hold
450,517
3.75% 12
2024
Q3
$1.21M Hold
450,517
0.79% 33
2024
Q2
$1.12M Hold
450,517
0.71% 36
2024
Q1
$1.07M Hold
450,517
0.18% 46
2023
Q4
$1.27M Buy
450,517
+94,326
+26% +$272K 0.19% 43
2023
Q3
$1.16M Buy
356,191
+300,511
+540% +$960K 0.22% 68
2023
Q2
$140K Buy
+55,680
New +$88.6K 0.02% 79

Other funds holding NSPR

Pura Vida Investments's NSPR Position: Q2 2026 in Review

Pura Vida Investments held its InspireMD (NSPR) position steady in Q2 2026 at 450,517 shares worth $315K. The position accounts for 0.85% of the portfolio, ranked #15.

Pura Vida Investments first reported a position in NSPR in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.27M in Q4 2023. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Pura Vida Investments held 450,517 shares of InspireMD worth $315K as of Q2 2026.
  • Pura Vida Investments left its InspireMD share count unchanged in Q2 2026.
  • InspireMD made up 0.85% of Pura Vida Investments's portfolio in Q2 2026, its #15 holding.
  • Pura Vida Investments first reported a position in InspireMD in Q2 2023 and has held it in 13 quarters since.
  • Pura Vida Investments's InspireMD position peaked at $1.27M in Q4 2023.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Pura Vida Investments's 13F filing for Q2 2026, filed 13 Aug 2026.